Anika manufactures hyaluronic acid-based medical devices and regenerative biologics for early-stage joint damage. The tech stack is heavily weighted toward manufacturing analytics and compliance (SAP, HPLC, LC-MS, GC/MS, ICP-MS) — reflecting a regulated, quality-intensive operation. Active projects cluster around process validation, facility upgrades, and software platform modernization, while hiring remains concentrated in manufacturing and operations, signaling capacity buildout to meet commercial demand.
Anika is a public medical device company founded in 1992, headquartered in Bedford, Massachusetts. They develop and commercialize minimally invasive products for orthopedic joint preservation, with a focus on osteoarthritis pain management and regenerative therapies. The portfolio includes branded products leveraging hyaluronic acid and proprietary biologics. The company operates across 201–500 employees, with manufacturing and operations forming the operational core, and sells into the global orthopedic clinic and hospital market.
Anika develops minimally invasive medical devices for joint preservation and early-stage osteoarthritis treatment, with product lines built around hyaluronic acid and regenerative biologics intended for orthopedic clinicians.
Anika's core tools include SAP (enterprise resource planning), analytical chemistry platforms (HPLC, LC-MS, GC/MS, ICP-MS for quality and compliance), Microsoft Office, and GCP. Heavy reliance on specialized lab instrumentation reflects regulated medical device manufacturing.
Anika is headquartered in Bedford, Massachusetts, and employs 201–500 people. The company is publicly traded and was founded in 1992.
Other companies in the same industry, closest in size